medications

Medication may provide some benefit for older adults with anxiety disorder

harminka — Wed, 21 Jan 2009 05:01:28 -0600

Preliminary research suggests that use of the drug escitalopram provided some improvement in symptoms for older adults with generalized anxiety disorder, although the overall benefits were diminished because of nonadherence to the drug by some patients, according to a study in the January 21 issue of JAMA.

Disclosure of medication can save a patient's life

harminka — Wed, 26 Nov 2008 00:16:54 -0600

Do you regularly take aspirin or antiplatelet medications? Do you know whether or not these drugs should be stopped before dental procedures or surgeries? According to a study published in the May/June issue of General Dentistry, the clinical, peer-reviewed journal of the Academy of General Dentistry (AGD), stopping antiplatelet medications prior to a surgical procedure places a patient at greater risk of permanent disability or death.

Higher co-payments reduce use of antidepressants

harminka — Sat, 07 Jun 2008 02:31:01 -0500

As they struggle to contain skyrocketing medication costs, health plans across the U.S. have responded by implementing multi-tiered formularies requiring higher copayments for 'non-preferred' medications.

Aging Institute Funds Smartphone Service for Medication

Armen Hareyan — Tue, 08 Apr 2008 09:35:30 -0500

The program by the National Institute of Aging hopes that the smartphone technology should improve compliance with taking prescription drugs for the elderly and disease management.

Sweden: Those in Debt Denied Medication

seher — Fri, 15 Feb 2008 12:34:37 -0600

Sweden’s pharmacy monopoly has all but given up on being paid the US$ 46.7 million it’s owed by customers who have charged their medications.

Rituxan may be called new drug for MS

seher — Thu, 14 Feb 2008 12:20:18 -0600

Doctors are encouraged by the results of a new study using a medication called Rituxan to help patients with multiple sclerosis (MS).

Study of successful drug targets could hasten development of new medications

harminka — Fri, 01 Feb 2008 09:21:00 -0600

Guidance from an innovative computational approach could speed up the process and cut down the cost of new drug development, researchers from the University of Chicago Medical Center and Columbia University suggest in a study to be published in the February 2008 issue of Genome Research, available early online.

China bans advertisements exaggerating drug benefits

Dinka — Wed, 07 Nov 2007 10:50:08 -0600

The State Food and Drug Administration in China ordered its local branches to assure the medication-producing companies remove the ads exaggerating the positive effects of their products.

Pediatricians warn: cold medications may be harmful

Dinka — Fri, 19 Oct 2007 10:31:30 -0500

American Academy of Pediatrics announced that cold and cough medications should be relabeled. Parents must know that the medications do not work in children under 6 and may be dangerous.

Medication 'may have killed' arthritis patient

Dinka — Mon, 15 Oct 2007 11:35:41 -0500

An inquest into the death of a 63-year-old Sydney woman has been told the medication she was prescribed for her arthritis may have been a factor in her death.

Patients can't recall their medications to tell doctors

harminka — Fri, 12 Oct 2007 11:06:25 -0500

Doctors rely on patients to accurately tell them what prescription medications – and what dosages -- they are taking in out-patient visits. (A patient's chart may not always be available or complete.) That information is essential for physicians to monitor whether a drug is working, and whether it may have adverse interactions with any new medications prescribed.

ECLIPSE data on effects of Otsuka's investigational novel treatment

harminka — Thu, 20 Sep 2007 06:46:47 -0500

A single dose of Otsuka’s investigational oral medication tolvaptan, a vasopressin receptor antagonist, resulted in favorable changes in hemodynamics associated with a significant increase in urine output in patients with advanced heart failure who participated in the international trial the EffeCt of ToLvaptan on HemodynamIc Parameters in Subjects with HEart failure, presented at the late breaking trials symposium of the Heart Failure Society of America’s Annual Scientific Meeting.